Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Exagen Inc
(NQ:
XGN
)
3.150
-0.040 (-1.25%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 7, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,258
Open
3.082
Bid (Size)
3.070 (1)
Ask (Size)
3.180 (2)
Prev. Close
3.190
Today's Range
3.082 - 3.170
52wk Range
2.038 - 8.960
Shares Outstanding
16,126,784
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Exagen Inc. to Participate in the William Blair 43rd Annual Growth Stock Conference
May 30, 2023
From
Exagen Inc.
Via
GlobeNewswire
Exagen: Q1 Earnings Insights
May 15, 2023
Via
Benzinga
Performance
YTD
+28.05%
+28.05%
1 Month
+12.46%
+12.46%
3 Month
+28.05%
+28.05%
6 Month
+30.71%
+30.71%
1 Year
-39.07%
-39.07%
More News
Read More
Recap: Exagen Q1 Earnings
May 15, 2023
Via
Benzinga
Exagen Inc. Reports First Quarter 2023 Results
May 15, 2023
From
Exagen Inc.
Via
GlobeNewswire
Exagen Announces Campaign for Lupus Awareness Month
May 01, 2023
From
Exagen Inc.
Via
GlobeNewswire
BTIG Maintains Buy Rating for Exagen: Here's What You Need To Know
March 22, 2023
Via
Benzinga
Exagen Earnings Perspective: Return On Capital Employed
March 21, 2023
Via
Benzinga
Earnings Scheduled For May 15, 2023
May 15, 2023
Via
Benzinga
Exagen to Announce First Quarter 2023 Financial Results on May 15, 2023
April 24, 2023
From
Exagen Inc.
Via
GlobeNewswire
Exagen Earnings Preview
March 17, 2023
Via
Benzinga
Nike, Tencent Music Entertainment And 3 Stocks To Watch Heading Into Tuesday
March 21, 2023
Via
Benzinga
Exagen Inc. Reports Fourth Quarter and Full Year 2022 Results
March 20, 2023
From
Exagen Inc.
Via
GlobeNewswire
Exagen to Announce Fourth Quarter and Full Year Financial Results on March 20, 2023
March 06, 2023
From
Exagen Inc.
Via
GlobeNewswire
Exagen Inc. to Participate in Upcoming March Conferences
February 27, 2023
From
Exagen Inc.
Via
GlobeNewswire
Coya Therapeutics' Expansion Of Exclusive Worldwide Licensing Agreement With ARscience Biotherapeutics Could Have Outsized Impact On Neurodegenerative And Autoimmune Diseases Treatments
February 15, 2023
Via
Benzinga
Exagen Inc. to Participate in the 2023 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
January 30, 2023
From
Exagen Inc.
Via
GlobeNewswire
Exagen Inc. Elects Tina S. Nova, Ph.D. as Executive Chair of the Board of Directors
January 23, 2023
From
Exagen Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
November 28, 2022
Via
Benzinga
Why Richardson Electronics Shares Surged Over 8%; Here Are 55 Biggest Movers From Friday
November 28, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
November 25, 2022
Via
Benzinga
Why Lufax Holding Shares Are Trading Lower By Over 11%; Here Are 21 Stocks Moving Premarket
November 25, 2022
Via
Benzinga
Why Coupa Software Shares Jumped Around 29%; Here Are 72 Biggest Movers From Wednesday
November 25, 2022
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
November 24, 2022
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
November 24, 2022
Via
Benzinga
Peering Into Exagen's Recent Short Interest
November 17, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.